Related Experiment Videos
Degenerative thalamic hamartoma: CT and MR imaging features
Tomoki Kaneko1, Rei Kawakami, Yasunari Fujinaga
1Department of Radiology, Shinshu University School of Medicine, Asahi, Matsumoto, Japan.
AJNR. American Journal of Neuroradiology
|May 14, 2004
Summary
This study details thalamic hamartomas, benign growths showing calcification and contrast enhancement on imaging. Histology confirmed glial outgrowth without neoplastic cells, suggesting a non-cancerous origin.
Area of Science:
- Neuropathology
- Neuroradiology
- Neuroscience
Background:
- Hamartomas are congenital hyperplastic malformations, often presenting as benign tumors.
- Thalamic lesions require precise characterization due to the thalamus's critical role in sensory and motor pathways.
- Differentiating hamartomas from neoplastic lesions is crucial for appropriate patient management.
Observation:
- Computed tomography (CT) demonstrated significant calcification within the thalamic mass.
- Magnetic resonance (MR) imaging revealed contrast enhancement, indicating vascularity.
- Histopathological examination showed glial cell outgrowth, consistent with hamartoma.
- Immunohistochemistry was positive for Neural Cell Adhesion Molecule (N-CAM) and negative for polysialic acid.
Findings:
- The imaging features (calcification, enhancement) and histological findings support a diagnosis of thalamic hamartoma.
- The absence of a neoplastic component was confirmed histologically.
- N-CAM positivity suggests glial differentiation, while negative polysialic acid may help differentiate from certain glial tumors.
Implications:
- Accurate diagnosis of thalamic hamartomas can prevent unnecessary aggressive treatment for benign conditions.
- Understanding the imaging and histological characteristics aids in differentiating these lesions from primary brain tumors.
- Further research into the molecular markers of hamartomas, like N-CAM, could refine diagnostic criteria.